Monday, April 11, 2022

< + > What sets the FDA apart on medtech innovation? An expert weighs in

UCLA Biodesign executive director Dr. Jennifer McCaney shares insights on a recent research project with BCG examining the global regulatory landscape, and discusses what excites her about the industry's future.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Bonus Features – June 21, 2026 – Only 14% of AI insights are fully integrated into decision-making processes, only 41% of consumers say AI tools are helpful in healthcare interactions, plus 34 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...